| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |